rabbit pab tfrc antibody (ABclonal Biotechnology)
ABclonal Biotechnology is a verified supplier 
90
Structured Review
ABclonal Biotechnology
rabbit pab tfrc antibody
Rabbit Pab Tfrc Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+pab+tfrc+antibody/tfrc+antibody/pm38978400-63-68-71
Average 90 stars, based on 1 article reviews
Rabbit Pab Tfrc Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+pab+tfrc+antibody/tfrc+antibody/pm38978400-63-68-71
Average 90 stars, based on 1 article reviews
rabbit pab tfrc antibody - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Western Blot:Article Title: A highly selective inhibitor of discoidin domain receptor-1 (DDR1-IN-1) protects corneal epithelial cells from YAP/ACSL4-mediated ferroptosis in dry eye. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82171020, 82201150 Background and Purpose: This study investigated the involvement of discoidin domain receptor (DDR) in dry eye and assessed the potential of specific DDR inhibitors as a therapeutic strategy for dry eye by exploring the underlying mechanism.. Experimental Approach: Dry eye was induced in Wistar rats by applying 0.2% benzalkonium chloride (BAC), after which rats were treated topically for 7 days with DDR1-IN-1, a selective inhibitor of DDR1.. Clinical manifestations of dry eye were assessed on Day-7 post-treatment. Immunofluorescence:Article Title: A highly selective inhibitor of discoidin domain receptor-1 (DDR1-IN-1) protects corneal epithelial cells from YAP/ACSL4-mediated ferroptosis in dry eye. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82171020, 82201150 Background and Purpose: This study investigated the involvement of discoidin domain receptor (DDR) in dry eye and assessed the potential of specific DDR inhibitors as a therapeutic strategy for dry eye by exploring the underlying mechanism.. Experimental Approach: Dry eye was induced in Wistar rats by applying 0.2% benzalkonium chloride (BAC), after which rats were treated topically for 7 days with DDR1-IN-1, a selective inhibitor of DDR1.. Clinical manifestations of dry eye were assessed on Day-7 post-treatment. Staining:Article Title: A highly selective inhibitor of discoidin domain receptor-1 (DDR1-IN-1) protects corneal epithelial cells from YAP/ACSL4-mediated ferroptosis in dry eye. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82171020, 82201150 Background and Purpose: This study investigated the involvement of discoidin domain receptor (DDR) in dry eye and assessed the potential of specific DDR inhibitors as a therapeutic strategy for dry eye by exploring the underlying mechanism.. Experimental Approach: Dry eye was induced in Wistar rats by applying 0.2% benzalkonium chloride (BAC), after which rats were treated topically for 7 days with DDR1-IN-1, a selective inhibitor of DDR1.. Clinical manifestations of dry eye were assessed on Day-7 post-treatment. |